CONFIRMED SPEAKERS:
- Ulrike Eggert (Dana Farber Cancer Institute, USA)
- Guri Giaever (University of Toronto, Canada)
- Todd Golub (Broad Institute, USA)
- Nathanael Gray (Dana Farber Cancer Institute, USA)
- Jeremy Jenkins (Novartis, USA)
- Joseph Lehar (CombinatoRx, USA)
- Muthiah Manoharan (Alnylam, USA)
- Cristiano Migliorini (Roche, Switzerland)
- Sarah O'Connor (Massachusetts Institute of Technology, USA)
- Randall Peterson (Massachusetts General Hospital, USA)
- Jean-Louis Reymond (University of Berne, Switzerland)
- Christopher Schofield (University of Oxford, UK)
- Stuart Schreiber (Broad Institute, USA)
- Brian Shoichet (University of California, San Francisco, USA)
- Kevan Shokat (University of California, San Francisco, USA)
- Giulio Superti-Furga (Center for Molecular Medicine, Austrian Academy of Sciences, Austria)
- Derek Tan (Memorial Sloan Kettering Cancer Center, USA)
- Gregory Verdine (Harvard University, USA)
- Peter Wipf (University of Pittsburgh, USA)
- Paul Workman (Cancer Research UK Centre for Cancer Therapeutics at The Institute of Cancer Research, UK)
Session Chairs:
- Carolyn Cho (Pfizer, USA)
- Gerard Drewes (Cellzome, Germany)
- Stephen Fesik (Vanderbilt University, USA)
- Michael Hann (GlaxoSmithKline, UK)
Main navigation
Top